• OPEN AN ACCOUNT
Indian Indices
Sensex
72,317.95 -162.34
( -0.22%)
Global Indices
Nasdaq
50,945.10 -425.82
(-0.83%)
Dow Jones
7,674.56 -17.28
(-0.22%)
Hang Seng
66,863.07 1,381.80
(2.11%)
Nikkei 225
10,610.72 -25.99
(-0.24%)
Forex
USD-INR
95.97 0.01
(0.01%)
EUR-INR
108.89 -0.26
(-0.24%)
GBP-INR
126.98 -0.19
(-0.15%)
JPY-INR
0.61 0.00
(0.01%)

EQUITY - MARKET SCREENER

Enfuse Solutions Ltd
Industry :  Computers - Software - Medium / Small
BSE Code
ISIN Demat
Book Value()
92697
INE0S3X01014
22.1727926
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ENFUSE
0
136.25
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

poonawalla fincorp limited
Bliss GVS Pharma consolidated net profit rises 128.96% in the March 2026 quarter
May 13,2026
Net profit of Bliss GVS Pharma rose 128.96% to Rs 35.58 crore in the quarter ended March 2026 as against Rs 15.54 crore during the previous quarter ended March 2025. Sales rose 29.80% to Rs 256.99 crore in the quarter ended March 2026 as against Rs 197.99 crore during the previous quarter ended March 2025.

For the full year,net profit rose 53.18% to Rs 129.13 crore in the year ended March 2026 as against Rs 84.30 crore during the previous year ended March 2025. Sales rose 14.50% to Rs 927.11 crore in the year ended March 2026 as against Rs 809.73 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales256.99197.99 30 927.11809.73 15
OPM %17.2910.65 -17.6915.65 -
PBDT53.5931.48 70 225.56155.06 45
PBT44.9223.44 92 192.08125.64 53
NP35.5815.54 129 129.1384.30 53